Is Methisazone Actually Worth The Money?

The target INR for this indication is 2��5. One study has suggested that there is a critical difference in outcomes, which is dependent on the INR in the period immediately before cardioversion (Gallagher et?al, 2002) and for this reason many units prefer the INR to be >2��5 in the period closest to the cardioversion. In the UK it is common practice to measure the INR on the day of the cardioversion and postpone the procedure if it is http://www.selleckchem.com/products/bay-57-1293.html INRs on the day of the procedure a target INR of 3��0 can be used prior to the procedure. Structural abnormalities of the heart and foreign surfaces, such as prosthetic valves, predispose to thrombus formation, which becomes clinically manifest through systemic embolization. This is usually an issue for surgeons and cardiologists and there are specific guidelines for this situation (Vahanian et?al, 2007; Salem et?al, 2008). In this guideline target INRs will be stated for the most common scenarios. ?Patients with mitral stenosis or regurgitation http://www.selleckchem.com/products/Roscovitine.html who have atrial fibrillation (1A) or a history of systemic embolism (1A) or left atrial thrombus (1A) or an enlarged left atrium (2C) should receive warfarin with an INR target of 2��5. 1.5.2?Mechanical prosthetic heart valves.? The risk of systemic embolism from prosthetic heart valves depends on the http://en.wikipedia.org/wiki/Methisazone type of valve, its position and other factors that contribute to the patients�� risk of developing thrombosis, such as cardiac rhythm and dilatation. The types of valves used in modern practice are typically less thrombogenic than older valves but there still are surviving patients with old style valves, such as the Starr-Edwards, in place. Many types of valves are available commercially and the data on anticoagulation and systemic embolism rates are mostly from prospective or retrospective case series. For new valves there are not sufficient data on the most appropriate level of anticoagulation and in these cases the valves should be regarded as medium thrombogenicity until there are adequate data to safely reduce the intensity of anticoagulation. Where studies purport to assess differences between different degrees of anticoagulation there is often a lack of clarity about time spent in range and so these are effectively ��intention to treat�� observations.